Viz.ai
Private Company
Total funding raised: $245.5M
Overview
Viz.ai is a pioneering AI-powered care coordination platform company founded in 2016. It has developed a comprehensive suite of FDA-cleared algorithms that auto-detect suspected diseases from medical scans (CT, EKG, echo) and facilitate real-time communication among care teams to accelerate treatment. The company serves both healthcare providers and life sciences partners, with solutions spanning neurovascular, cardiovascular, vascular, trauma, oncology, and radiology. Viz.ai is a private, revenue-generating company positioned at the intersection of AI diagnostics and clinical workflow optimization.
Technology Platform
Viz.ai One® is an AI-powered care coordination platform featuring over 50 FDA-cleared algorithms that analyze medical imaging (CT, EKG, echo) to auto-detect suspected diseases. It integrates detection with real-time communication tools, workflow orchestration (Viz Assist), and a configurable pathway builder (Viz Agent Studio) to accelerate treatment in time-sensitive conditions.
Funding History
5Opportunities
Risk Factors
Competitive Landscape
Viz.ai competes with pure-play AI imaging companies like Aidoc and Avicenna.ai, as well as large medical imaging OEMs (GE HealthCare, Siemens, Canon) who are embedding AI into their scanners and software. Its key differentiation is the integrated care coordination platform that combines detection with communication and workflow, rather than being a standalone diagnostic aid.